Kahn LH, Alderfer RJ, Graham DJ
Teach-back is effective across a wide range of settings, populations, and outcome measures, including patients with T2DM [256]
Biological Activity Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM)
Medical Interactions: If you are undergoing chemotherapy (specifically with drugs like cisplatin or cyclophosphamide), consult your oncologist first, as heavy antioxidants can potentially alter medication efficacy
The SURMOUNT-4 withdrawal trial showed that patients regain approximately half of lost weight within one year of stopping tirzepatide, highlighting that obesity is a chronic disease requiring ongoing management rather than a condition cured by temporary treatment
Hers makes getting a GLP-1 prescription for weight loss straightforward and approachable